Use of Tegwondo, a near-continuous temozolomide regimen, in high- and low-grade gliomas.

被引:1
|
作者
Strik, H. M.
Bock, H. C.
Marosi, C.
机构
[1] Univ Marburg, Marburg, Germany
[2] Univ Gottingen, D-37073 Gottingen, Germany
[3] Med Univ Vienna, Dept Med 1, Div Clin Oncol, Vienna, Austria
[4] Med Univ Vienna, Ctr Comprehens Canc, Vienna, Austria
关键词
D O I
10.1200/jco.2011.29.15_suppl.2084
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
2084
引用
收藏
页数:1
相关论文
共 50 条
  • [31] Dynamic history of low-grade gliomas before and after temozolomide treatment
    Ricard, Damien
    Kaloshi, Gentian
    Amiel-Benoualch, Alexandra
    Lejeune, Julie
    Marie, Yannick
    Mandonnet, Emmanuel
    Kujas, Michele
    Mokhtari, Karima
    Taillibert, Sophie
    Laigle-Donadey, Florence
    Carpentier, Antoine F.
    Omuro, Antonio
    Capelle, Laurent
    Duffau, Hugues
    Cornu, Philippe
    Guillevin, Remy
    Sanson, Marc
    Hoang-Xuan, Khe
    Delattre, Jean-Yves
    ANNALS OF NEUROLOGY, 2007, 61 (05) : 484 - 490
  • [32] "Long extended" temozolomide in a selected population with not radically resected high-grade gliomas.
    Spinelli, Gian Paolo
    Lo Russo, Giuseppe
    Miele, Evelina
    Alberti, Antonio Maria
    Strudel, Martina
    Stati, Valeria
    Zoratto, Federica
    Papa, Anselmo
    Rossi, Luigi
    Verrico, Monica
    Basso, Enrico
    Giordani, Erika
    Zaccarelli, Eleonora
    Minozzi, Marina
    Pisanelli, Giovanni Codacci
    Tomao, Silverio
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [33] IMPACT OF TEMOZOLOMIDE CHEMOTHERAPY ON SEIZURE FREQUENCY IN PATIENTS WITH LOW-GRADE GLIOMAS
    Sherman, Jonathan H.
    Moldovan, Kriszrina
    Yeoh, Hian K.
    Starke, Bobby M.
    Pouratian, Nader
    Shaffrey, Mark E.
    Schiff, David
    NEURO-ONCOLOGY, 2010, 12 : 38 - 38
  • [34] IMPACT OF TEMOZOLOMIDE CHEMOTHERAPY ON SEIZURE FREQUENCY IN PATIENTS WITH LOW-GRADE GLIOMAS
    Sherman, Jonathan
    Yeoh, Hian
    Pouratian, Nader
    Prevedello, Daniel
    Aregawi, Dawir
    Shaffrey, Mark
    Schiff, David
    NEURO-ONCOLOGY, 2008, 10 (05) : 832 - 832
  • [35] Impact of temozolomide chemotherapy on seizure frequency in patients with low-grade gliomas
    Sherman, Jonathan H.
    Moldovan, Krisztina
    Yeoh, H. Kwang
    Starke, Robert M.
    Pouratian, Nader
    Shaffrey, Mark E.
    Schiff, David
    JOURNAL OF NEUROSURGERY, 2011, 114 (06) : 1617 - 1621
  • [36] [18F]Fluciclovine PET discrimination between high- and low-grade gliomas
    Parent, Ephraim E.
    Benayoun, Marc
    Ibeanu, Ijeoma
    Olson, Jeffrey J.
    Hadjipanayis, Constantinos G.
    Brat, Daniel J.
    Adhikarla, Vikram
    Nye, Jonathon
    Schuster, David M.
    Goodman, Mark M.
    EJNMMI RESEARCH, 2018, 8
  • [37] [18F]Fluciclovine PET discrimination between high- and low-grade gliomas
    Ephraim E. Parent
    Marc Benayoun
    Ijeoma Ibeanu
    Jeffrey J. Olson
    Constantinos G. Hadjipanayis
    Daniel J. Brat
    Vikram Adhikarla
    Jonathon Nye
    David M. Schuster
    Mark M. Goodman
    EJNMMI Research, 8
  • [38] A phase II study of a temozolomide-based chemoradiotherapy regimen for high-rish low-grade gliomas: Preliminary results of RTOG 0424
    Fisher, Barbara Jean
    Lui, Jeff
    Macdonald, David R.
    Lesser, Glenn Jay
    Coons, Stephen
    Brachman, David
    Ryu, Samuel
    Werner-Wasik, Maria
    Bahary, Jean-Paul
    Hu, Chen
    Mehta, Minesh P.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [39] The potential role of 18F-FDOPA PET imaging in low-grade gliomas.
    Carapella, Carmine Maria
    Villani, Veronica
    Chiaravalloti, Agostino
    Plludu, Francesca
    Terrenato, Irene
    Vidirl, Antonello
    Fahl, Alessandra
    Schillacl, Orazlo
    Pace, Andrea
    Floris, Roberto
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [40] Temozolomide-induced hypermutation is associated with high-grade transformation, distant recurrence, and reduced survival after transformation in initially low-grade IDH-mutant diffuse gliomas.
    Bush, Nancy Ann Oberheim
    Yu, Yao
    Villanueva-Meyer, Javier
    Grimmer, Matthew
    Hilz, Stephanie
    Solomon, David
    Choi, Serah
    Mazor, Tali
    Hong, Chibo
    Shai, Anny
    Phillips, Joanna J.
    McDermott, Mike
    Haas-Kogan, Daphne A.
    Taylor, Jennie
    Butowski, Nicholas A.
    Clarke, Jennifer
    Berger, Mitchel
    Molinaro, Annette
    Chang, Susan Marina
    Costello, Joseph
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)